These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 14986482)

  • 21. [Clinicopathological features of familial amyloid polyneuropathy].
    Koike H; Sobue G
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1134-7. PubMed ID: 22277509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
    Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
    ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings.
    Yoshioka A; Yamaya Y; Saiki S; Hirose G; Shimazaki K; Nakamura M; Ando Y
    Arch Neurol; 2001 Nov; 58(11):1914-8. PubMed ID: 11709003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.
    Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A
    Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
    Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
    J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
    Andrés N; Poza JJ; Martí Massó JF
    Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
    Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
    J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
    Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
    J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
    Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
    Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset familial amyloid polyneuropathy in Japan.
    Koike H; Sobue G
    Amyloid; 2012 Jun; 19 Suppl 1():55-7. PubMed ID: 22506939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution ultrastructure of amyloid fibrils in familial amyloid polyneuropathy.
    Katsuragi S; Miyakawa T; Ando Y; Terazaki H
    J Electron Microsc (Tokyo); 2000; 49(4):579-81. PubMed ID: 12005198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
    Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
    Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report.
    Sakashita N; Ando Y; Obayashi K; Terazaki H; Yamashita T; Takei M; Kinjo M; Takahashi K
    Virchows Arch; 2000 Apr; 436(4):345-50. PubMed ID: 10834537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.
    Suhr OB; Wixner J; Anan I; Lundgren HE; Wijayatunga P; Westermark P; Ihse E
    PLoS One; 2019; 14(2):e0211983. PubMed ID: 30811423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan.
    Ikeda S; Takei Y; Tokuda T; Nakazato M; Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():39-47. PubMed ID: 14640041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas.
    Koike H; Tanaka F; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Fujitake J; Kawanami T; Kato T; Yamamoto M; Sobue G
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):152-8. PubMed ID: 22228785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.